Why Does Biotech Regulation Differ So Much Between The US And EU?

MOspace/Manakin Repository

Breadcrumbs Navigation

Why Does Biotech Regulation Differ So Much Between The US And EU?

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/442

[+] show full item record


Title: Why Does Biotech Regulation Differ So Much Between The US And EU?
Author: Kalaitzandonakes, Nicholas G., 1960-
Keywords: mad cow disease
Date: 2000
Publisher: AgBioForum
Citation: AgBioForum 3(2&3) 2000: 75-76.
Abstract: When it comes to agricultural biotechnology, public policies in the United States (US) and the European Union (EU) have been radically different. In the US, products of agricultural biotechnology have been extensively tested and marketed. In the EU, few biotechnology products have received regulatory approval while most have faced a de-facto moratorium. The tough regulatory stance of the EU towards agricultural biotechnology has typically been justified on the basis of public skepticism towards the technology and heightened concerns about food safety in the wake of the mad cow disease outbreak and other recent food scares.
URI: http://hdl.handle.net/10355/442
ISSN: 1522-936X

This item appears in the following Collection(s)

[+] show full item record